These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 33199207)

  • 1. Overweight improves long-term survival in Japanese patients with asthma.
    Yano C; Kawayama T; Kinoshita T; Tokunaga Y; Sasaki J; Sakazaki Y; Matsuoka M; Imaoka H; Nishiyama M; Matsunaga K; Furukawa K; Hoshino T
    Allergol Int; 2021 Apr; 70(2):201-207. PubMed ID: 33199207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma.
    Drick N; Milger K; Seeliger B; Fuge J; Korn S; Buhl R; Schuhmann M; Herth F; Kendziora B; Behr J; Kneidinger N; Bergmann KC; Taube C; Welte T; Suhling H
    J Asthma Allergy; 2020; 13():605-614. PubMed ID: 33204117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Night shift work is associated with an increased risk of asthma.
    Maidstone RJ; Turner J; Vetter C; Dashti HS; Saxena R; Scheer FAJL; Shea SA; Kyle SD; Lawlor DA; Loudon ASI; Blaikley JF; Rutter MK; Ray DW; Durrington HJ
    Thorax; 2021 Jan; 76(1):53-60. PubMed ID: 33199525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 inflammation in eosinophilic chronic obstructive pulmonary disease.
    Higham A; Beech A; Wolosianka S; Jackson N; Long G; Kolsum U; Southworth T; Pham TH; Sridhar S; McCrae C; Newbold P; Singh D
    Allergy; 2021 Jun; 76(6):1861-1864. PubMed ID: 33206402
    [No Abstract]   [Full Text] [Related]  

  • 5. Real-life study in non-atopic severe asthma patients achieving disease control by omalizumab treatment.
    Campo P; Soto Campos G; Moreira A; Quirce S; Padilla-Galo A; Martínez-Moragón E; Mardones A; Dávila I
    Allergy; 2021 Jun; 76(6):1868-1872. PubMed ID: 33220106
    [No Abstract]   [Full Text] [Related]  

  • 6. A systematic review and meta-analysis of risk factors associated with atopic dermatitis in Asia.
    Ng YT; Chew FT
    World Allergy Organ J; 2020 Nov; 13(11):100477. PubMed ID: 33204388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission and Changes in Severity Over 30 Years in an Adult Asthma Cohort.
    Tupper OD; Håkansson KEJ; Ulrik CS
    J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1595-1603.e5. PubMed ID: 33220516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overlap of allergic, eosinophilic and type 2 inflammatory subtypes in moderate-to-severe asthma.
    Chen M; Shepard K; Yang M; Raut P; Pazwash H; Holweg CTJ; Choo E
    Clin Exp Allergy; 2021 Apr; 51(4):546-555. PubMed ID: 33217063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen sulfide as a novel biomarker of asthma and chronic obstructive pulmonary disease.
    Suzuki Y; Saito J; Munakata M; Shibata Y
    Allergol Int; 2021 Apr; 70(2):181-189. PubMed ID: 33214087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic treatment options for severe asthma.
    Hearn AP; Kent BD; Jackson DJ
    Curr Opin Immunol; 2020 Oct; 66():151-160. PubMed ID: 33212388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Corticosteroids Tapering in Severe Asthma.
    Boulet LP; Godbout K
    Am J Respir Crit Care Med; 2021 Apr; 203(7):795-796. PubMed ID: 33211979
    [No Abstract]   [Full Text] [Related]  

  • 12. Distinct expression of SARS-CoV-2 receptor ACE2 correlates with endotypes of chronic rhinosinusitis with nasal polyps.
    Wang M; Bu X; Fang G; Luan G; Huang Y; Akdis CA; Wang C; Zhang L
    Allergy; 2021 Mar; 76(3):789-803. PubMed ID: 33210729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergy and immunology in young children of Japan: The JECS cohort.
    Yamamoto-Hanada K; Pak K; Saito-Abe M; Yang L; Sato M; Irahara M; Mezawa H; Sasaki H; Nishizato M; Ishitsuka K; Ohya Y;
    World Allergy Organ J; 2020 Nov; 13(11):100479. PubMed ID: 33204389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of entheseal IL-23 expression by IL-4 and IL-13 as an explanation for arthropathy development under dupilumab therapy.
    Bridgewood C; Sharif K; Freeston J; Saleem B; Russell T; Watad A; Khan A; Loughenbury P; Rao A; Wittmann M; McGonagle D
    Rheumatology (Oxford); 2021 May; 60(5):2461-2466. PubMed ID: 33253386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized Comparative Clinical Study of First Global Omalizumab Biosimilar with Innovator Product in Moderate to Severe Persistent Asthma.
    Apsangikar P; Ghadge P; Naik M; Nair S
    J Assoc Physicians India; 2020 Dec; 68(12):61-65. PubMed ID: 33247645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type-2 inflammatory mediators as targets for precision medicine in children.
    Castagnoli R; Licari A; Manti S; Chiappini E; Marseglia GL
    Pediatr Allergy Immunol; 2020 Nov; 31 Suppl 26():17-19. PubMed ID: 33236434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 and allergy: How to take care of allergic patients during a pandemic?
    Cianferoni A; Votto M
    Pediatr Allergy Immunol; 2020 Nov; 31 Suppl 26(Suppl 26):96-101. PubMed ID: 33236431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Epigenetics in the Chronic Sinusitis with Nasal Polyp.
    Liu T; Sun Y; Bai W
    Curr Allergy Asthma Rep; 2020 Nov; 21(1):1. PubMed ID: 33236242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordant use of short-acting β
    Gorlanova O; Tischhauser E; Adcock IM; Chung KF; Fleming L; Meier D; Sterk PJ; Roberts G; Roberts A; Singer F; Sousa AR; Uddin M; Frey U;
    Pediatr Pulmonol; 2021 Feb; 56(2):338-340. PubMed ID: 33231935
    [No Abstract]   [Full Text] [Related]  

  • 20. The Role of Biologics in Chronic Rhinosinusitis with Nasal Polyps.
    Bachert C; Desrosiers MY; Hellings PW; Laidlaw TM
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1099-1106. PubMed ID: 33227522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.